The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
As major financial institutions pivot toward strengthening positions in cash-rich corporations, Cibc World Market has increased its stake in Cisco by 9% through the purchase of 108,662 additional shares. The firm also boosted its investment in pharmaceutical giant Merck by 32.6%, bringing its total holding value to $137 million. These moves are driven by Cisco's expansion in AI and cybersecurity, alongside Merck's robust drug pipeline, which recently saw calderasib receive an FDA breakthrough designation.
This institutional accumulation reflects growing confidence in the healthcare and tech sectors relative to peers; for instance, Pfizer recently reported quarterly results that beat estimates while focusing on cost-cutting, whereas Cisco continues to challenge Juniper Networks in network infrastructure. Per market data, these investments occur as large-cap firms show resilience against interest rate volatility. Analyst reports suggest the Merck position is partly supported by the growth of Keytruda, which generated $25 billion in revenue in 2023 (per company earnings reports).
Sign in to access this content
Sign InTraders should watch current price levels, as Cisco (CSCO) closed at $47.20 and Merck (MRK) at $128.50 (close June 3, 2026). Looking ahead, the market will focus on upcoming US inflation data, with the Core PCE Price Index scheduled for release on May 28, a critical catalyst for Fed policy decisions that directly impact the valuation of tech-sector growth stocks.